GH1 and cancer: Hirsch and Gross-Tsur hypothesized that increases in insulin-like factor-1 as a result of GH treatment over the course of several decades in PWS adults raise concern over the possible increase in the risk of cancer (43), although there is no evidence to date of a clear correlation between GH therapy and cancer risk in PWS subjects (14, 28).